Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
Author:
Publisher
S. Karger AG
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Reference20 articles.
1. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension
2. Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
3. Disease Pathways and Novel Therapeutic Targets in Hypertrophic Cardiomyopathy
4. Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
5. Pirfenidone
Cited by 128 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. At the heart of inflammation: Unravelling cardiac resident macrophage biology;Journal of Cellular and Molecular Medicine;2024-09
2. Zebrafish as an innovative model for exploring cardiovascular disease induction mechanisms and novel therapeutic interventions: a molecular insight;Molecular Biology Reports;2024-08-12
3. Pirfenidone Prevents Heart Fibrosis during Chronic Chagas Disease Cardiomyopathy;International Journal of Molecular Sciences;2024-07-03
4. Pirfenidone use in fibrotic diseases: What do we know so far?;Immunity, Inflammation and Disease;2024-07
5. CYP1A2 Polymorphism and Drug Co-administration Affect the Blood Levels and Adverse Effects of Pirfenidone;Therapeutic Drug Monitoring;2024-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3